Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2018 Nov 28;115(50):E11614–E11622. doi: 10.1073/pnas.1816606115

Phage Mu Gam protein promotes NHEJ in concert with Escherichia coli ligase

Sudipta Bhattacharyya a,1, Michael M Soniat a, David Walker a, Sooin Jang a,2, Ilya J Finkelstein a,3, Rasika M Harshey a,3
PMCID: PMC6294893  PMID: 30487222

Significance

Prophages constitute a large portion of the abundant phage genomes on our planet. They live in symbiosis with their host, replicating together, and potentially conferring increased fitness. Many fitness-enhancing prophage functions are known, famously the cholera toxin, but the majority are unknown. Prophage Mu encodes numerous genes of undetermined function. The product of one of these, Gam, protects linear DNA ends from exonucleases. We report two distinct roles for MuGam, both involved in promoting survival of the phage and of its host under conditions where the bacterial genome suffers double-stranded DNA breaks. The novel finding is that MuGam, in concert with Escherichia coli ligase, endows the cell with a nonhomologous end-joining repair pathway.

Keywords: phage MuGam, E. coli ligase, RecBCD, NHEJ, viral DNA packaging

Abstract

The Gam protein of transposable phage Mu is an ortholog of eukaryotic and bacterial Ku proteins, which carry out nonhomologous DNA end joining (NHEJ) with the help of dedicated ATP-dependent ligases. Many bacteria carry Gam homologs associated with either complete or defective Mu-like prophages, but the role of Gam in the life cycle of Mu or in bacteria is unknown. Here, we show that MuGam is part of a two-component bacterial NHEJ DNA repair system. Ensemble and single-molecule experiments reveal that MuGam binds to DNA ends, slows the progress of RecBCD exonuclease, promotes binding of NAD+-dependent Escherichia coli ligase A, and stimulates ligation. In vivo, Gam equally promotes both precise and imprecise joining of restriction enzyme-digested linear plasmid DNA, as well as of a double-strand break (DSB) at an engineered I-SceI site in the chromosome. Cell survival after the induced DSB is specific to the stationary phase. In long-term growth competition experiments, particularly upon treatment with a clastogen, the presence of gam in a Mu lysogen confers a distinct fitness advantage. We also show that the role of Gam in the life of phage Mu is related not to transposition but to protection of genomic Mu copies from RecBCD when viral DNA packaging begins. Taken together, our data show that MuGam provides bacteria with an NHEJ system and suggest that the resulting fitness advantage is a reason that bacteria continue to retain the gam gene in the absence of an intact prophage.


Genomes are subject to chemical and physical damage from both endogenous and exogenous processes. Repair of the resulting damage is essential for survival of all life forms, and many mechanisms exist for reversing specific types of damage (1). The bulk of DNA damage affects one strand, where it impedes replication fork progression, resulting in replication fork collapse and double-strand breaks (DSBs), which, if unrepaired or incorrectly repaired, can lead to chromosomal rearrangements, oncogenic transformation, and cell death (2, 3). DSBs are repaired by two major pathways: homologous recombination (HR) and nonhomologous end joining (NHEJ) (2, 46). HR is found in all organisms studied, and relies on the presence of two DNA copies, so that the HR machinery can restore the damage by copying information from the undamaged homolog, which serves as a template for DNA synthesis across the break. NHEJ, on the other hand, acts during situations when only one chromosomal copy is available, and joins the broken DNA directly. The NHEJ pathway was first identified in mammalian cells (7); this pathway is found in both unicellular and multicellular eukaryotes (6), as well as in archae (8). The core constituents of the NHEJ pathway are Ku proteins that bind DNA ends at DSBs in a sequence- and overhang-independent manner, and recruit a dedicated ATP-dependent ligase complex that seals the break. NHEJ does not generally return the DNA to its original sequence, the imprecision contributing to genomic mutations, a process that vertebrates have taken advantage of in generating antigen receptor diversity in the immune system. During the last decade, identification of homologs of eukaryotic Ku proteins and ATP-dependent ligases (LigD) in several bacteria, for example Mycobacterium, Pseudomonas, Bacillus, Streptomyces, and Agrobacterium species, has confirmed that NHEJ operates in prokaryotes as well (911).

The Gam protein of transposable bacteriophage Mu shares sequence similarity with eukaryotic and bacterial Ku proteins (12). Mu is a temperate phage, which uses transposition to propagate itself during both lysogenic and lytic phases of growth (13, 14). The lysogenic repressor controls the transcription of a long early transcript (15) that encodes the essential transposition genes (A, B) followed by a cluster of 14 genes categorized for historical reasons as semiessential (SE) (16, 17). These genes are expressed constitutively in the prophage (18), but their function is largely unknown. The Gam gene is in this cluster and was so named because it complemented the Gam gene of phage λ (19), which inhibits the RecBCD nuclease (20). Purified MuGam was shown to specifically bind linear dsDNA as a homodimer, and protect against ExoV (RecBC) and other exonucleases (12, 2124), an action different from that of λGam, which binds to RecBCD to inactivate it (25). A fluorescent MuGam−GFP fusion has recently been used to detect DSBs in both Escherichia coli and mammalian cells, and has been demonstrated to block RecBCD activity in a λΔgam plaque assay (26). Overproduction of Gam has been reported to stimulate transformation efficiency of linear plasmid DNA (23), suggesting that Gam might be useful for acquiring foreign DNA. Gam homologs were identified in several pathogenic bacteria, and one of these—HiGam encoded by a Mu-like prophage in Haemophilus influenzae—was purified and shown to have properties similar to MuGam in binding linear DNA and protecting against exonuclease III (12). Despite the known biochemical properties of Gam, its function in the lifecycle of Mu is not known.

We show, in this study, that MuGam is a true homolog of Ku in that it promotes NHEJ by suppressing the DNA degradation activities of RecBCD and by recruiting an NAD+-dependent ligase to the free DNA ends. This role for MuGam in conferring NHEJ to bacterial cells is consistent with the survival advantage it confers on the host bacterium during long-term culture and when treated with clastogens. We also deduce a role for Gam in the life of Mu and speculate why Gam is only found in Mu-like phages.

Results and Discussion

A Bacterial Homolog of MuGam Is Structurally Similar to Eukaryotic Ku.

Gam-encoding genes were identified earlier in four bacterial species that carried near-complete Mu prophage sequences (12). Our search for MuGam homologs identified them only in bacterial phyla, always linked to either complete or partial Mu-like sequences (SI Appendix, Fig. S1A). Many bacterial orders in these phyla also had Ku homologs that always accompanied LigD, but the presence of Gam was independent of LigD (SI Appendix, Fig. S1B). There are currently no available structures of bacterial Ku proteins, but the structure of a MuGam homolog from Desulfovibrio vulgaris (Dv) shows similarities with eukaryotic Ku (Fig. 1). In contrast to heterodimeric eukaryotic Ku, DvGam is a homodimer in the crystal structure, as are the solution states of mycobacterial Ku (27) and MuGam (12). A homology model built for MuGam looked similar to the DvGam structure (Fig. 1). The central cavity in DvGam is similar to the one that holds DNA in eukaryotic Ku in that both cavities are surrounded by conserved positively charged amino acid residues sterically well suited for interacting with negatively charged DNA. However, this cavity in DvGam is twice as wide as that in Ku (28), and could potentially accommodate two DNA helices, or undergo a structural constriction upon DNA binding. The N-terminal region of DvGam is a long antiparallel alpha helix with no additional subdomains; in the eukaryotic Ku heterodimer, this region is more complex, likely providing a docking platform for other NHEJ-associated proteins such as XRCC4, XLF, and PKcs (reviewed in ref. 29).

Fig. 1.

Fig. 1.

Structural comparison of eukaryotic Ku, bacterial Gam, and MuGam. (Upper Left) Crystal structure of DvGam homodimer (PDB ID code 2P2U). (Upper Right) A homology model of phage MuGam dimer (see Methods). (Lower Left) Crystal structure of a eukaryotic Ku heterodimer (PDB ID code 1JEQ). (Lower Right) Ku in presence of dsDNA (PDB ID code 1JEY). Positively charged amino acid residues projecting into the central DNA-binding cavity for Ku, and into the equivalent space for Gam, are represented as sticks. The central cavity in DvGam is twice as wide as that in Ku (36 Å × 65 Å vs. 30 Å × 24 Å).

Multiple MuGam Dimers Can Load on a DNA End.

EMSA assays showed that MuGam preferentially binds linear DNA with an estimated Kd of ∼12 nM (Fig. 2A) (12, 21, 24). The ladder of bands further indicated that multiple Gam dimers can load on the substrate, as has been observed for the eukaryotic Ku complex. Next, we employed high-throughput single-molecule DNA curtains to image MuGam as it interacts with the DNA substrate (30, 31). In this assay, thousands of individual DNA molecules (∼48.5 kb long, derived from λ-phage DNA) are organized at microfabricated chromium barriers and visualized by total internal reflection fluorescence microscopy. For fluorescence imaging, MuGam was purified with an N-terminal FLAG epitope tag (see Methods and SI Appendix, Fig. S2) and labeled with a fluorescent anti-FLAG antibody before injection into the DNA curtain. The anti-FLAG antibody was conjugated with a quantum dot (QD) that emits in the 705-nm range (magenta in Fig. 2B). Most Gam molecules bound the DNA, although a few associated with the lipid bilayer, as observed when buffer flow was turned off (Fig. 2B). As expected, injecting the antibody-conjugated QD alone did not result in any DNA-bound molecules. Gam binding position was mapped by fitting the point spread function to a 2D Gaussian profile (Fig. 2C). Gam was located predominantly at the ends of the DNA (67%; n = 277/413). To determine whether multiple Gam dimers could load on the same DNA end, we first injected Gam labeled with a 605-nm QD (green), followed by Gam that was labeled with a magenta QD into the same flow cell. Approximately 70% (n = 56/80) of the DNA molecules had two differentially labeled Gams that were colocalized stably at the same DNA end (t1/2 = >2,000 s) (Fig. 2D). These experiments demonstrate that at least two Gam dimers, but possibly even larger assemblies, can load on the free DNA end. In summary, the ensemble and single-molecule experiments demonstrate that multiple Gam dimers can bind to linear DNA ends.

Fig. 2.

Fig. 2.

MuGam is located predominantly at DNA ends. (A) EMSA assay. Linear dsDNA (100 bp) was incubated with increasing amounts of tagless Gam, electrophoresed on a 5% native acrylamide gel, and visualized by ethidium bromide (EtBr) staining. C, DNA alone control. Position of size markers is indicated on the right. (B) Fluorescent FLAG-Gam (magenta) binds λ−DNA organized at microfabricated barriers (green, labeled with YOYO1 dye). Turning off buffer flow retracts both Gam and DNA to the barriers (black arrow), indicating that Gam is on the DNA. (C) A binding distribution of Gam along the DNA shows a strong preference for DNA ends. Gray region indicates the experimental uncertainty in defining the DNA end. Error bars were determined by bootstrap analysis. Red line denotes the Gaussian fit. (D) Multiple FLAG-Gam molecules can stack on a free DNA end, as indicated by colocalization of green- and magenta-labeled Gams on a single DNA molecule. Position of the Gam-bound DNA end is indicated. Orange dashed line and black horizontal bar indicate when the magenta Gam was injected into the flow cell. See Methods for experimental details.

MuGam Slows but Does Not Block RecBCD Degradation.

The reported ability of Gam to protect bound DNA from a variety of exonucleases (21, 24) was tested with the most potent E. coli exonuclease, RecBCD (32). RecBCD is an ATP-dependent helicase and nuclease that initiates DNA degradation from free DNA ends. We therefore tested whether RecBCD can access and degrade MuGam-bound DNA ends. In this assay, the activity of WT RecBCD was visualized as the degradation of a fluorescently labeled DNA molecule as a function of time (Fig. 3A) (33, 34). We observed that MuGam is pushed by RecBCD as the DNA shortens (Fig. 3A). The velocity and processivity of RecBCD on MuGam-bound DNA was calculated to be 0.93 ± 0.6 kb⋅s−1 and 33 ± 8.3 kb, respectively (Fig. 3B; n = 40). In comparison, RecBCD’s velocity was 1.41 ± 0.5 kb⋅s−1 and the processivity was 35 ± 10.8 kb on naked DNA (n = 100) (see also ref. 35). This processivity likely underestimates the RecBCD in vivo because a significant fraction of the nucleases digested the entire ∼48.5-kb-long DNA substrate in a single reaction (SI Appendix, Fig. S3A) (36). In contrast, RecBCD rarely digested Gam-bound DNA to completion in the single-molecule assay (SI Appendix, Fig. S3A). Strikingly, MuGam also reduces the velocity of RecBCD. In addition, the half-life of MuGam on DNA in the presence of RecBCD was 87 ± 3 s (n = 40) (Fig. 3C), which is significantly higher than that of other tight binding DNA protein complexes that encounter RecBCD (35). The sequence similarity between MuGam and Ku (12) suggests that it may encircle DNA similar to Ku, possibly making MuGam more difficult to remove by RecBCD. Although the half-life was higher than other DNA binding proteins, >98% of MuGam molecules were eventually removed within 300 s by RecBCD. In 100% of these events (n = 40), MuGam dissociated only after RecBCD ceased translocating and presumably also uncapped the DNA end (Fig. 3A). These results are consistent with MuGam surrounding the DNA duplex while RecBCD pushes it during DNA translocation. We note that our experimental setup precluded using higher MuGam:DNA ratios because Gam aggregates interacted with the flow cell surface at higher concentrations. Thus, the partial RecBCD inhibition observed here likely underestimates how a large train of Gams may inhibit RecBCD in vivo. These findings were confirmed in bulk experiments using purified RecBCD, as well as whole cell extracts as the source of this enzyme, where MuGam-bound DNA was observed to survive longer than unbound DNA (SI Appendix, Fig. S3 B and C). We conclude that MuGam slows DNA degradation by RecBCD but does not stop it completely.

Fig. 3.

Fig. 3.

Gam slows RecBCD progress. (A) (Upper) Illustration and (Lower) representative kymograph of RecBCD digesting DNA (green) containing FLAG-Gam (magenta). Dashed line indicates when RecBCD was added to the flow cell. RecBCD is not fluorescently labeled. (B) Distribution of RecBCD velocities and processivities on naked and Gam-bound DNA. Box plots indicate the median, 10th, and 90th percentiles of the distributions (n = 40). ****P < 0.0001; n.s., not significant. More than 95% of Gam-bound DNA molecules were processed by RecBCD (very similar to RecBCD processing of naked DNA), suggesting that Gam doesn’t significantly block RecBCD loading under these experimental conditions. (C) Upon colliding with RecBCD, Gam remains associated with DNA more than 16-fold longer than E. coli RNA polymerase, EcoRI(E111Q), and nucleosomes (also see ref. 35).

MuGam Stimulates Ligation by E. coli Ligase A and Promotes Its Binding to DNA Ends.

Given the similarity of MuGam to Ku (12), we tested whether MuGam would promote joining of restriction enzyme-digested sticky DNA ends by ligase. We used both the ATP-dependent DNA ligase from phage T4 and the NAD+-dependent ligase A (LigA) from E. coli. Gam stimulated ligation by LigA, and not by T4 ligase (Fig. 4A). While the ligation reaction with LigA was stimulated threefold to fivefold, that with T4 ligase was inhibited, suggesting specificity of the Gam−LigA reaction. To test whether MuGam−LigA interaction could be visualized using DNA curtains, we purified an HA-tagged version of LigA (SI Appendix, Fig. S4A, Left); MuGam also stimulated ligation with (HA)2-LigA (SI Appendix, Fig. S4B, Left). When QD-labeled LigA was introduced into the flow cell containing MuGam-bound DNA, LigA was seen to colocalize with MuGam, and persist at that end with a half-life of ∼180 ± 30 s (n = 25) (Fig. 4B). This localization was not observed in the absence of Gam (SI Appendix, Fig. S4C).

Fig. 4.

Fig. 4.

Gam binding stimulates E. coli DNA LigA activity. (A) The 550-bp substrate DNA (C) with noncomplementary sticky ends (EcoRI/SalI) was incubated with increasing molar ratios of tagless Gam before the addition of E. coli LigA (Left) or T4DNA ligase (Right). DNA:Gam molar ratios in Left were 1:10, 1:20, and 1:40; only the first two ratios were used in Right. Reaction products were analyzed by agarose gel electrophoresis and visualized with EtBr. (B) Representative kymograph of FLAG-Gam (green) colocalizing with (HA)2-Lig A (magenta). White arrow denotes LigA dissociation. The half-life of LigA with Gam localization is ∼3 min (n = 25).

LigA is the primary and essential ligase in E. coli, required for the ligation of the Okazaki fragments during DNA replication (37, 38). E. coli also has a second nonessential NAD+-dependent ligase B (LigB), which is reported to be less efficient than LigA (39, 40). We purified an HA-tagged version of LigB (SI Appendix, Fig. S4A, Right), which showed lower ligation efficiency, as expected, but MuGam nonetheless stimulated DNA ligation by (HA)2-LigB (SI Appendix, Fig. S4B, Right). In the DNA curtain setup, however, LigB localization to Gam-bound ends was not observed (SI Appendix, Fig. S4D). We conclude that MuGam interacts with LigA to promote ligation of linear DNA ends. LigB can also participate in this reaction, but at a ower efficiency.

MuGam Promotes Precise Joining of Linear Plasmid DNA.

To test whether Gam promotes joining of linear DNA ends in vivo, a CmR plasmid encoding GFP was cut with NdeI to remove a major portion of the gene encoding GFP. Mu lysogens that differed only in the presence or absence of gam were transformed with the gel-isolated plasmid backbone (Fig. 5A). Overproduction of MuGam has been reported to stimulate transformation efficiency by linear plasmid DNA (23). The uncut plasmid was therefore also transformed into the two strains, and the recovery of the CmR, GFP plasmid was expressed as a ratio, GFP/GFP+ colonies. There was ∼100-fold higher recovery of CmR, GFP colonies in the Gam+ strain compared with the Gam strain (Fig. 5B). Plasmids isolated from 20 CmR, GFP colonies from each strain were sequenced, and the repair junctions were analyzed. Half of those from the Gam+ strain had precisely joined the NdeI cut, while the remaining plasmids had deletions of ∼1 to 500 bp on either side of the initial cut, the joints displaying either no homology or microhomology over a few nucleotides (Fig. 5C). In contrast, there was no precise joining of the NdeI–cut ends in plasmids recovered from the Gam strain, which otherwise showed similar deletion sizes, and microhomologies across the joint. Thus, Gam promotes efficient joining of sticky DNA ends in vivo, half of these events being precise. From experiments presented in Figs. 4 and 5, we conclude that Gam assists NHEJ.

Fig. 5.

Fig. 5.

Gam promotes efficient repair of linear plasmid DNA in vivo. (A) Schematic of the experimental setup. RE, restriction enzyme (NdeI). (B) Recovery of CmR GFP colonies in Gam+ (HM8305) and Gam (SB02) Mu lysogens. The data are normalized for transformation efficiency using the uncut CmR GFP+ plasmid. (C) Sequence summary of 20 CmR GFP plasmids from each strain.

MuGam Promotes Precise Joining of I-SceI Resected Chromosomal DNA, Preferentially in the Stationary Phase.

To test whether a chromosomal break could be sealed in the presence of Gam, we used a strain with a chromosomal I-SceI site located close to the origin of replication (oriC) (26). In this strain, Gam is expressed from a tetracycline-inducible promoter, and I-SceI is expressed from an arabinose-inducible promoter, both from chromosomal locations. Overproduction of Gam, whether from a plasmid or a regulated promoter on the chromosome, is toxic to the cell (26, 41). Spot assays were therefore first carried out to titrate the amount of Gam induction that was nonlethal. Pilot experiments showed improved survival if LigA levels were increased, so ligA was also provided on an Isopropyl-β-D-thiogalactoside (IPTG)-inducible plasmid. Without induction of Gam and LigA expression, I-SceI induction killed ∼85% of cells under exponential growth conditions and ∼99% in the stationary phase (Fig. 6A). Expression of Gam or LigA alone did not improve cell survival (Gam alone being more detrimental), whereas expression of both showed a ∼100-fold increase in survival only in the stationary phase. The critical difference between exponential and stationary phases for these experiments is the presence of a sister copy in the former but not in the latter. To test whether the HR machinery might be masking Gam activity in the exponential phase, we repeated the experiment using an isogenic RecA strain. In the absence of HR, we observed ∼99% cell killing in the exponential phase, but the presence of Gam and LigA showed a 100-fold increase in survival in this growth phase, similar to that seen in the stationary phase for both RecA+ and RecA strains. Repair junctions at the I-SceI site were examined by whole genome sequencing of the cultures (i.e., before determining survivor counts) in both growth phases in the RecA strain. The results were similar for both (Fig. 6B). As observed for the linear plasmid DNA joints (Fig. 5C), nearly 50% of the chromosomal joints were also precise repairs. The remaining joints had deletions spanning ∼1 kb, and either no homology or 1- to 7-nt microhomology (SI Appendix, Fig. S5 for deletion sizes). These data are consistent with a role for Gam in NHEJ preferentially in the stationary phase in the WT strain.

Fig. 6.

Fig. 6.

Expression of Gam and LigA together increases survival of cells experiencing a chromosomal DSB. (A) The host strain was either RecA+ (SMR14353) or isogenic RecA (ΔRecA; SB08), and experiments were conducted in either the exponential or stationary phase. Relative cell survival was scored by counting cfus under the indicated experimental conditions (+/− representing induction of relevant proteins), and normalized to the lowest cell count (∼105) obtained in any single experiment. (B) Repair junctions of chromosomal breaks in RecA cells. Of the exponential phase genomes examined (n = 865), nearly 50% of all sequences (n = 426) were perfect repairs. Of the remaining, 28% (n = 240) had repair joints with no homology, 13% (n = 118) had joints with 1 nt of homology, and 9% (81) had joints between 2 nt and 7 nt of homology. The repair trend was similar in the stationary phase genomes (n = 1,240). Nearly 50% (n = 595) showed accurate repair, 27% (n = 341) repaired with no homology, 17% (n = 218) with 1 nt of homology, and the remaining 3% (n = 86) between 2 nt and 7 nt of homology. See SI Appendix, Fig. S5 for deletion sizes at the repair joints.

MuGam Confers Improved Fitness in Growth Competition Experiments.

The retention of MuGam homologs in multiple bacterial phyla even in the absence of a complete Mu (SI Appendix, Fig. S1A) suggests that Gam-promoted NHEJ may provide a survival advantage when DNA damage occurs in the stationary phase, where a template for HR is unavailable (9). To test this proposition, we cocultured isogenic Mu lysogens that differed only in the presence or absence of gam. The strains were mixed together at a similar culture density (OD600) and grown continuously for 72 h in either rich or minimal media, withdrawing aliquots at the indicated intervals for determining colony-forming units (cfus) (Fig. 7 A and B and SI Appendix, Fig. S6 A and B). In rich media, the Gam strain had a growth advantage at early times, but the Gam+ strain outcompeted the Gam strain over the long term, the advantage manifesting clearly after ∼20 h (Fig. 7A). The same trend was seen in minimal media (Fig. 7B), except that the Gam+ strain did not display the disadvantage in the exponential phase seen in rich media (Fig. 7A). Relative fitness of the Gam+ over the Gam strain was calculated to be 1.03 in rich media, and 1.1 in minimal media (see Methods). Both values are considered to be significant with a 95% confidence interval (CI95) and will be favored by natural selection (42). The disadvantage of Gam+ during the exponential phase in rich media (Fig. 7A) might be due to Gam interference with HR. The clear advantage of Gam+ during the stationary phase is consistent with the function of NHEJ during times when a sister DNA copy is not available for repair by HR.

Fig. 7.

Fig. 7.

Presence of Gam increases host fitness. (A and B) Gam+ (Lac+) and Gam (Lac) Mu lysogens (DMW61 and DMW154) were mixed together in (A) LB or (B) M9 media at similar OD600 values, and propagated continuously at 30 °C for 72 h without changing the media, as described in Methods. Aliquots were removed at the indicated times to determine cfus, scoring for Lac+ and Lac phenotypes on Mackonkey agar to distinguish the two strains. The data are a summary of at least three biological repeats done in triplicates. Reversing the strains carrying the Lac+ and Lac alleles [i.e., Gam+ (Lac) and Gam (Lac+)] gave similar results overall, showing that the particular Lac allele does not significantly affect the outcome (SI Appendix, Fig. S6). The relative fitness of the Gam+ over the Gam strain was calculated to be 1.03 (CI95 = ±0.0001) in LB and 1.1 (CI95 = ±0.02) in M9. (C and D) As in A and B, except the mixed culture was treated with phleomycin before the start of the growth competition experiment. Dashed lines represent a concurrent experiment without the phleomycin treatment. The relative fitness in LB for the phleomycin treated cultures was 1.03 (CI95 = ±0.007) and, in M9, 1.07 (CI95 = ±0.012). The control no-phleomycin results were similar to those in A and B.

The data in Figs. 46 show that Gam joins DSBs both in vitro and in vivo. We therefore expected that treatment with a clastogen such as phleomycin, which induces DSBs (43), would also reveal a fitness advantage for the Gam+ strain in long-term cultures. The experimental setup was similar to the one shown in Fig. 7 A and B, except that survival profiles of phleomycin-treated and untreated mixtures of Gam+ and Gam strains were monitored. The Gam+ strain showed an immediate advantage after phleomycin treatment (Fig. 7 C and D and SI Appendix, Fig. S6 C and D). This advantage was seen even in rich media, in contrast to the untreated control (here and in Fig. 7A). The early onset of a survival advantage could be due to high amounts of chromosomal damage in unreplicated DNA in the phleomycin-treated cells that could not be handled by HR alone. Overall, these data are consistent with the NHEJ function of MuGam.

Gam Is Not Required for Mu Transposition, but Is Apparently Involved in Protecting Mu Replicas from RecBCD When DNA Packaging Ensues.

The life cycle of Mu is summarized in SI Appendix, Fig. S8A. Infecting Mu DNA is linear. An injected phage protein MuN binds to the linear ends noncovalently and circularizes the DNA, protecting it from exonucleases (ref. 41 and references therein). After transposition into the E. coli genome, Mu can either enter a prophage state or go through the lytic cycle, during which the Mu genome is amplified by repeated replicative transposition into the E. coli genome, followed by packaging of chromosomal Mu replicas. Since MuGam binds to linear DNA ends, a backup role for Gam in protecting linear infecting Mu DNA has been speculated (12). However, a Mu variant missing the SE region, which includes gam, was fully proficient in Mu lysogeny, ruling out such a role (44). A role for Gam in replicative transposition is also ruled out, given the similar lysis profiles of a MuΔgam lysogen compared with WT Mu (Fig. 8A). We noticed, however, that the phage titers obtained from MuΔgam were consistently threefold to fivefold lower (Fig. 8B). These titers were restored to WT levels if the strain carried a recB deletion, indicating that the lower titers of MuΔgam were likely related to generation of RecBCD-susceptible DSBs (Fig. 8B). However, DSBs are not expected during replicative transposition (14). To test whether Mu replication/transposition was inhibited in the Δgam strain, Mu copy numbers during the lytic cycle were estimated by real-time PCR first for WT Mu, by isolating E. coli genomic DNA at various time points (Fig. 8C). Mu copy numbers were seen to double first around 15 min after induction of Mu transposition, and then approximately every 5 min, leveling off around 40 min, at which time mature phage were observed when cells were lysed artificially, suggesting that packaging of Mu replicas into phage heads had begun before 40 min. We then compared the WT Mu genomic copy numbers to those in the MuΔgam strain at 0, 15, and 30 min after induction of lytic growth (Fig. 8D). In both strains, Mu copies doubled at 15 min, indicating that replication was not delayed in the Δgam strain. Mu genomic copies decreased slightly at 30 min for MuΔgam, a time at which packaging is expected to have started (Fig. 8D). Mu replicas are packaged from their chromosomal locations by a head-full mechanism starting at the left end, with host DNA flanking both sides of the insertion included in the virion genome (45). Initiation of packaging would leave a chromosomal DSB flanking at this end first, and then on both sides of the Mu copy after packaging was complete (Fig. 8G). We surmised that the effect of Gam was likely being manifested at this stage, when the phage genome being packaged is itself protected from RecBCD, but the DNA adjacent to the packaged genome is vulnerable, and this adjacent DNA is likely to include another copy of Mu that gets degraded. This would explain the lower phage titers in a gam strain (Fig. 8B). To test when packaging begins, we tracked the appearance of chromosomal DSBs by using MuGam−GFP expressed from plasmid, as demonstrated in other experiments (26, 41). In a time course after Mu induction, fluorescent Gam foci began to appear around 33 min, and the nucleoid was studded with foci by 36 min (Fig. 8E). Cells began to lyse at around 40 min. Cells that did not show foci never lysed, and no fluorescent foci were observed in the absence of Mu induction. This experiment was repeated by infecting Mu into a strain that expressed MuGam−GFP on the chromosome from the λPR promoter; the GFP foci were more distinct, and the results were similar (Fig. 8F and SI Appendix, Fig. S7). We conclude that Gam is primarily involved in protecting Mu progeny in the genome from destruction by RecBCD toward the end of the lytic cycle (Fig. 8G).

Fig. 8.

Fig. 8.

Role of Gam in the Mu life cycle. (A) Lysis curves of the following lysogens: WT Mu (HM8305), MuΔgam (SB02), and MuΔgam in a ΔrecB host (SB03). (B) Plaque forming units (PFU) released after induction of strains shown in A. (C) Real-time PCR analysis of WT chromosomal Mu copies (relative to a single copy gene hipA) at indicated times after induction of Mu replication. (D) As in C, except a comparison of WT and ∆gam chromosomal Mu copies at indicated times after induction. (E and F) Appearance of Gam-GFP foci toward the end of Mu lytic cycle. In E, Gam-GFP is expressed from a plasmid. (Upper) Twenty-five minutes after MuΔgam prophage induction (SB77), cells were placed on agar pads and monitored under phase contrast for GFP fluorescence for indicated times after induction. The red arrow points to a cell that eventually lysed. (Inset) A larger image of the 34-min sample, with a different contrast to highlight the foci. (Lower) The same culture imaged without Mu induction. In F, Gam-GFP is expressed at a chromosomal location from lambda PR promoter, under control of a thermosensitive repressor (SMR16470). This strain was infected with WT Mu, propagated in liquid medium for 40 min at 42 °C, and transferred to agar pads, where punctate cells began lysing almost immediately (see Methods). The time course of appearance of the puncta was similar to that in E, with no puncta above background in control cells held at for 40 min at 42 °C (SI Appendix, Fig. S7). Red arrow points to a lysing cell. (G) Model showing the protective role of Gam at the chromosomal end (black line) of the break during packaging of Mu replicas (red line) into phage heads. [Magnification: E and F, 1,000×.]

Summary and Perspective

We have established, in this study, that MuGam is a functional homolog of Ku proteins in that it promotes NHEJ in concert with E. coli LigA (the weak stimulation with LigB needs further study). The difference between Gam and Ku NHEJ is that the ligase is NAD+-dependent rather than ATP-dependent. We speculate that the larger central cavity in bacterial Gam (Fig. 1; compare DvGam and Ku) might facilitate capture and pairing of the second DNA end after Gam loads on the first one, by stably (or transiently) housing both ends to promote joining. We also identify, in this study, a role for Gam in the lifecycle of Mu, which is related to its function of reducing RecBCD activity, i.e., protection of DSBs generated in the chromosome during Mu packaging. Thus, Gam has at least two separate functions: protecting DSBs against exonucleases and repairing them by NHEJ. The former is important for survival of Mu, but both are important for survival of the host. In the host, the DSB protection function of Gam likely aids the transformation efficiency of naturally competent bacteria (23), contributing to long-term evolution of the host by acquisition of foreign DNA as has been suggested before (12, 23). The NHEJ function of Gam likely contributes to the increased fitness of host strains in the stationary phase as demonstrated in this study.

Why is Gam specifically associated with transposable Mu-like phages (SI Appendix, Fig. S1A), when there is no apparent need for Gam in transposition per se (Fig. 8)? Other phages like λ and T4 also have exposed double-strand ends during replication that need protection. Why have these phages evolved alternate mechanisms to inhibit RecBCD, using proteins that directly bind to the nuclease (20, 4648)? RecBCD is essential for the repair of broken genomic DNA by HR (32). We suggest that λ and T4 inhibit RecBCD directly because they carry their own recombination functions, and do not need the HR function of RecBCD. By contrast, Mu does not encode known HR functions, and needs the host RecBCD at two distinct stages of lysogeny that require repair of both Mu and host DNA as summarized in SI Appendix, Fig. S8. When infecting Mu transposes into the E. coli genome, it waits for the E. coli replication fork (SI Appendix, Fig. S8B, Left), the arrival of which triggers two events. One event is generation of a DSB on the lagging strand of chromosomal DNA when the fork encounters the single-strand nick at the Mu−host junction resulting from the nick–join event of Mu transposition (SI Appendix, Fig. S8B, Middle); this DSB must be repaired by HR (41, 44). The other event is degradation by RecBCD of the flanking host DNA still attached to the Mu insertion intermediate, followed by repair of the insertion (SI Appendix, Fig. S8B, Right) (41, 49, 50). RecBCD is therefore essential for recovery of a stable Mu lysogen (44). We suggest that Gam is found preferentially in Mu-like prophages because it has evolved a function that protects linear DNA ends without having to debilitate RecBCD.

Methods

See SI Appendix for standard protein purification methods, RecBCD assays, repair/recovery of cut plasmids, and details of chromosomal DSB recovery, Mu growth, and qPCR.

Strain Construction and Growth Conditions.

Bacterial strains, plasmids, and primers used in this work are listed in SI Appendix, Tables S1–S3. Bacteria were generally propagated in Luria Broth (LB) media unless otherwise stated. The Mu gam gene was deleted in lysogenic strains using λ-Red recombination system (51), substituting it with a KanR cassette flanked by flippase recognition target (FRT) sites. Δlac and ∆recA were constructed by the same method, except that GenR cassette from pkD46-GenR plasmid was substituted for recA (52). The antibiotic resistance-linked versions of the gene deletions were moved to other backgrounds using phage P1 transduction (53), and the resistance cassette was either retained or removed later by Flp recombinase from pCP20, which leaves an 82- to 85-bp FRT scar in the place of the deleted gene.

MuGam Homology Modeling and Phylogenetic Analysis.

The best structural template for MuGam was identified through I-TASSER (iterative threading assembly refinement) (54), where the crystal structure of DvGam [Protein Data Bank (PDB) ID code 2P2U] was found to be the closest structural homolog (rmsd 2.52 Å). The homology model of MuGam was prepared by SWISS MODEL (https://swissmodel.expasy.org/) and Swiss-PDBViewer (55), and was found to be structurally similar to the model obtained through I-TASSER. The geometry optimization of the MuGam dimer model was carried out by PHENIX (Python-based Hierarchical Environment for Integrated Xtallography) (56). Stereochemical property of the model was assessed by RAMPAGE (57). PyMOL (www.pymol.org/) was used to create all of the structural representations.

Amino acid sequence alignment between Mycobacterium tuberculosis Ku and MuGam is not significant, allowing a clear distinction between the two in Position-Specific Iterated Basic Local Alignment Search Tool searches (58), which were performed using either MuGam or M. tuberculosis Ku and LigaseD as query against a reference protein (Refseq) database (https://www.ncbi.nlm.nih.gov/refseq/) for each major phylum under the bacterial domain. The searches were performed with a minimum threshold expect value of 0.0001. The three domains of life representing major bacterial phyla are prepared by iTOL (Interactive Tree of Life) (59). Partial Mu sequences were identified by PHASTER (Phage Search Tool Enhanced Release) searches (60).

DNA Curtain Experiments.

DNA substrates were prepared for single-molecule imaging by annealing the appropriate oligos to bacteriophage λ DNA (NEB) at 65 °C, ligating the DNA overnight with T4 DNA ligase (NEB), and heat inactivation of the ligase. The DNA substrates were purified through an S1000 gel filtration column to remove enzymes and excess oligos (GE) (41). The gel-filtered DNA was used directly during flow cell assembly and stored at 4 °C for up to a month.

DNA curtains were assembled on microfabricated microscope slides, as described previously (30, 31). All single-molecule data were collected at 37 °C in imaging buffer [40 mM Tris⋅HCl (pH 8.0), 2 mM MgCl2, 1 mM ATP, 1 mM DTT, 0.2 mg⋅mL−1 BSA] on a Nikon Ti-E microscope in a prism total internal reflection fluorescence configuration. The flow cells were illuminated by a 488-nm laser light (Coherent) through a quartz prism. A 60× water immersion objective (1.2 NA; Nikon), a 500-nm long-pass filter (Chroma) and a 638-nm dichroic beam splitter (Chroma), and two electron multiplying charge-coupled device cameras (AndoriXon DU897, cooled to −80 °C) allowed data to be collected at a 200-ms exposure. Images were collected, saved as uncompressed TIFF files using the NIS-Elements software, and analyzed via custom-written image processing script implemented in ImageJ and MATLAB (all analysis scripts are available via GitHub at https://github.com/finkelsteinlab/imagej-particle-tracking-script).

FLAG-Gam was conjugated to QDs by first preincubating a biotinylated anti-FLAG antibody (F9291; Sigma-Aldrich) with streptavidin QDs [Q10163MP for 705 (magenta) or Q10103MP for 605 (green); Life Technologies] on ice for 10 min. Next, FLAG-Gam was incubated with the anti-FLAG QDs for an additional 10 min on ice, diluted to 40 nM with BSA buffer containing free biotin, and injected into the flow cell at 0.2 mL⋅min−1 in BSA buffer over several minutes. After all free FLAG-Gam was washed out, the flow cell was switched to imaging buffer containing 0.5 nM YOYO1 (Invitrogen), 1.4 mM glucose, glucose oxidase, and catalase to visualize DNA. Following injection of YOYO-1, 20 nM RecBCD was injected into the flow cell at 0.4 mL⋅min−1.

Quantification and statistical analyses were done using MATLAB (version: R2015b). For processivity and velocity measurements, position distribution measurements and particle tracking were conducted as previously described (61). The lifetimes of FLAG-Gam were defined as the time FLAG-Gam remained on the DNA after RecBCD was injected into the flow cell. The survival histogram (Fig. 3B) was fitted with a single exponential decay to extract the half-life. Errors bars represent the CI95 of the fit of the exponential time constant.

For FLAG-Gam and (HA)2-LigA or (HA)2-LigB colocalization experiments, FLAG-Gam was labeled as above and injected into the flow cell at 0.2 mL⋅min−1 in BSA buffer. Following wash-out of free FLAG-Gam, 40 nM (HA)2-LigA or (HA)2-LigB that were labeled with anti-HA antibody (RHGT-45A-Z; ICL Lab) conjugated QDs were injected into flow cell at 0.4 mL⋅min−1.

Repair of I-SceI Mediated Chromosomal dsDNA Breaks.

The overall experimental flow was as follows: Induce LigA/Gam in cells growing in rich media to either the exponential or stationary phase, before I-SceI induction. Wash and resuspend these cells in minimal media for the duration of I-SceI induction. Allow repair of the DNA damage for several hours in minimal media without a usable carbon source, before monitoring survival by cfus or preparing genomic DNA for sequencing to assess the damage. See SI Appendix for details.

Fitness Experiments.

Single colonies of the Gam+ and Gam strains distinguished by their Lac+ or Lac phenotypes were inoculated into separate flasks containing 10 mL of LB or M9 glucose to initiate experimental populations. When OD600 reached ∼0.5, they were mixed together at similar OD values and propagated continuously at 30 °C without changing the medium. In experiments involving phleomycin treatment, 1 µg/mL of phleomycin (Fischer Scientific) showed roughly 50% killing as determined by a spot assay after treatment of Gam+ cultures for 25 min at 30 °C, with shaking. This concentration was therefore used to similarly treat the combined strain mixture. Treated cultures were washed three times in sterile 0.1 M NaCl, added to the appropriate media (LB or M9), and propagated continuously at 30 °C as above, along with controls without phleomycin treatment run at the same time for comparison. At various time points, aliquots were washed with 0.1 M NaCl three times, diluted, and plated on Mackonkey agar to differentiate Lac+ and Lac cell populations.

Relative fitness (W) values for Gam+ and Gam cells were calculated according to the formula [adapted from Barrick Lab protocol for experimental evolution (barricklab.org/twiki/bin/view/Lab/ProtocolList#Experimental_Evolution)]

W=log(MGam+)/log(MGam),

where MGam+ (Malthusian parameter for Gam+ strain) = NA(f)/NA(i) = PCA(f) * DF/PCA(i) (Malthusian parameter is defined as “the intrinsic rate of natural increase”); MGam-(Malthusian parameter for Gam strain) = NB(f)/NB(i) = PCB(f) * DF/PCB(i); N is cell number; PC is plate count; DF is dilution factor of all transfers combined; A and B are the two strains being tested; and i and f are the initial and final time points.

Visualization of GamGFP Foci During the Mu Lytic Cycle in Vivo.

This experiment was performed both by induction of a Mu prophage and by infection with phage. For induction, Gam-GFP was expressed from a rhamnose-inducible plasmid promoter (pGam-GFP) in a MuΔgam lysogen (SB77); SB77 cells were grown in M9 media (0.2% glucose, 0.2% CAS amino acids) to an OD600 ≈ 0.6; Gam-GFP production was induced by the addition of 100 μM l-rhamnose for 1 h at 30 °C, after which rhamnose concentration was increased to 300 μM and the cell culture was shifted to 42 °C to induce Mu transposition/replication; and cell aliquots were removed at 25 min postinduction and placed on an M9 agarose (1.5%) pad for imaging at room temperature. For infection, Gam-GFP was expressed from a chromosomal location, where Gam-GFP is under lambda PR control (SMR16470); this strain was infected with WT Mu (from HM8305) at a multiplicity of infection of 5, and incubated for 40 min at 42 °C, where the thermosensitive Mu and lambda repressors are both inactivated; cell aliquots were placed on agar pads as above and visualized with an Olympus BX53 fluorescence microscope; and images were captured using cellSens standard software (version 1.6) from Olympus. Both bright-field and GFP images were taken as cells began to lyse.

Supplementary Material

Supplementary File

Acknowledgments

We thank Susan Rosenberg and Makkuni Jayaram for strains and reagents. This work was supported by National Institutes of Health Grants GM118085 (to R.M.H.) and GM120554, GM097177, and CA092584 (to I.J.F.), and, in part, by the Robert Welch Foundation Grants F-1811 (to R.M.H.) and F1808 (to I.J.F.). M.M.S. is supported by a Postdoctoral Fellowship, PF-17-169-01-DMC, from the American Cancer Society.

Footnotes

The authors declare no conflict of interest.

This article is a PNAS Direct Submission.

Data deposition: Analysis scripts have been deposited on GitHub (available at https://github.com/finkelsteinlab/imagej-particle-tracking-script).

This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1816606115/-/DCSupplemental.

References

  • 1.Iyama T, Wilson DM., 3rd DNA repair mechanisms in dividing and non-dividing cells. DNA Repair (Amst) 2013;12:620–636. doi: 10.1016/j.dnarep.2013.04.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ceccaldi R, Rondinelli B, D’Andrea AD. Repair pathway choices and consequences at the double-strand break. Trends Cell Biol. 2016;26:52–64. doi: 10.1016/j.tcb.2015.07.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Aparicio T, Baer R, Gautier J. DNA double-strand break repair pathway choice and cancer. DNA Repair (Amst) 2014;19:169–175. doi: 10.1016/j.dnarep.2014.03.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Cromie GA, Connelly JC, Leach DR. Recombination at double-strand breaks and DNA ends: Conserved mechanisms from phage to humans. Mol Cell. 2001;8:1163–1174. doi: 10.1016/s1097-2765(01)00419-1. [DOI] [PubMed] [Google Scholar]
  • 5.Mehta A, Haber JE. Sources of DNA double-strand breaks and models of recombinational DNA repair. Cold Spring Harb Perspect Biol. 2014;6:a016428. doi: 10.1101/cshperspect.a016428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Lieber MR. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem. 2010;79:181–211. doi: 10.1146/annurev.biochem.052308.093131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Roth DB, Porter TN, Wilson JH. Mechanisms of nonhomologous recombination in mammalian cells. Mol Cell Biol. 1985;5:2599–2607. doi: 10.1128/mcb.5.10.2599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Wilson TE, Topper LM, Palmbos PL. Non-homologous end-joining: Bacteria join the chromosome breakdance. Trends Biochem Sci. 2003;28:62–66. doi: 10.1016/S0968-0004(03)00005-7. [DOI] [PubMed] [Google Scholar]
  • 9.Pitcher RS, Brissett NC, Doherty AJ. Nonhomologous end-joining in bacteria: A microbial perspective. Annu Rev Microbiol. 2007;61:259–282. doi: 10.1146/annurev.micro.61.080706.093354. [DOI] [PubMed] [Google Scholar]
  • 10.Shuman S, Glickman MS. Bacterial DNA repair by non-homologous end joining. Nat Rev Microbiol. 2007;5:852–861. doi: 10.1038/nrmicro1768. [DOI] [PubMed] [Google Scholar]
  • 11.Bowater R, Doherty AJ. Making ends meet: Repairing breaks in bacterial DNA by non-homologous end-joining. PLoS Genet. 2006;2:e8. doi: 10.1371/journal.pgen.0020008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.d’Adda di Fagagna F, Weller GR, Doherty AJ, Jackson SP. The Gam protein of bacteriophage Mu is an orthologue of eukaryotic Ku. EMBO Rep. 2003;4:47–52. doi: 10.1038/sj.embor.embor709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Symonds N, Toussaint A, Van de Putte P, Howe MM, editors. Phage Mu. Cold Spring Harbor Lab; Cold Spring Harbor, NY: 1987. [Google Scholar]
  • 14.Harshey RM. Transposable phage Mu. In: Craig NL, editor. Mobile DNA III. ASM Press; Washington, DC: 2015. pp. 669–691. [Google Scholar]
  • 15.Goosen N, van de Putte P. Regulation of transcription. In: Symonds N, Toussaint A, Van de Putte P, Howe MM, editors. Phage Mu. Cold Spring Harbor Lab; Cold Spring Harbor, NY: 1987. pp. 41–52. [Google Scholar]
  • 16.Paolozzi L, Symonds N. The SE Region. Cold Spring Harbor Lab Press; Cold Spring Harbor, NY: 1987. [Google Scholar]
  • 17.Morgan GJ, Hatfull GF, Casjens S, Hendrix RW. Bacteriophage Mu genome sequence: Analysis and comparison with Mu-like prophages in Haemophilus, Neisseria and Deinococcus. J Mol Biol. 2002;317:337–359. doi: 10.1006/jmbi.2002.5437. [DOI] [PubMed] [Google Scholar]
  • 18.Saha RP, Lou Z, Meng L, Harshey RM. Transposable prophage Mu is organized as a stable chromosomal domain of E. coli. PLoS Genet. 2013;9:e1003902. doi: 10.1371/journal.pgen.1003902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Van Vliet F, Couturier M, De Lafonteyne J, Jedlicki E. Mu-1 directed inhibition of DNA breakdown in Escherichia coli, recA cells. Mol Gen Genet. 1978;164:109–112. doi: 10.1007/BF00267606. [DOI] [PubMed] [Google Scholar]
  • 20.Murphy KC. Lambda Gam protein inhibits the helicase and chi-stimulated recombination activities of Escherichia coli RecBCD enzyme. J Bacteriol. 1991;173:5808–5821. doi: 10.1128/jb.173.18.5808-5821.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Williams JG, Radding CM. Partial purification and properties of an exonuclease inhibitor induced by bacteriophage Mu-1. J Virol. 1981;39:548–558. doi: 10.1128/jvi.39.2.548-558.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Akroyd JE, Clayson E, Higgins NP. Purification of the gam gene-product of bacteriophage Mu and determination of the nucleotide sequence of the gam gene. Nucleic Acids Res. 1986;14:6901–6914. doi: 10.1093/nar/14.17.6901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Akroyd J, Symonds N. Localization of the gam gene of bacteriophage mu and characterisation of the gene product. Gene. 1986;49:273–282. doi: 10.1016/0378-1119(86)90288-x. [DOI] [PubMed] [Google Scholar]
  • 24.Abraham ZH, Symonds N. Purification of overexpressed gam gene protein from bacteriophage Mu by denaturation-renaturation techniques and a study of its DNA-binding properties. Biochem J. 1990;269:679–684. doi: 10.1042/bj2690679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Karu AE, Sakaki Y, Echols H, Linn S. The gamma protein specified by bacteriophage gamma. Structure and inhibitory activity for the recBC enzyme of Escherichia coli. J Biol Chem. 1975;250:7377–7387. [PubMed] [Google Scholar]
  • 26.Shee C, et al. Engineered proteins detect spontaneous DNA breakage in human and bacterial cells. eLife. 2013;2:e01222. doi: 10.7554/eLife.01222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Weller GR, et al. Identification of a DNA nonhomologous end-joining complex in bacteria. Science. 2002;297:1686–1689. doi: 10.1126/science.1074584. [DOI] [PubMed] [Google Scholar]
  • 28.Walker JR, Corpina RA, Goldberg J. Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair. Nature. 2001;412:607–614. doi: 10.1038/35088000. [DOI] [PubMed] [Google Scholar]
  • 29.Downs JA, Jackson SP. A means to a DNA end: The many roles of Ku. Nat Rev Mol Cell Biol. 2004;5:367–378. doi: 10.1038/nrm1367. [DOI] [PubMed] [Google Scholar]
  • 30.Gallardo IF, et al. High-throughput universal DNA curtain arrays for single-molecule fluorescence imaging. Langmuir. 2015;31:10310–10317. doi: 10.1021/acs.langmuir.5b02416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Soniat MM, et al. Next-generation DNA curtains for single-molecule studies of homologous recombination. Methods Enzymol. 2017;592:259–281. doi: 10.1016/bs.mie.2017.03.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Dillingham MS, Kowalczykowski SC. RecBCD enzyme and the repair of double-stranded DNA breaks. Microbiol Mol Biol Rev. 2008;72:642–671. doi: 10.1128/MMBR.00020-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Bianco PR, et al. Processive translocation and DNA unwinding by individual RecBCD enzyme molecules. Nature. 2001;409:374–378. doi: 10.1038/35053131. [DOI] [PubMed] [Google Scholar]
  • 34.Handa N, Bianco PR, Baskin RJ, Kowalczykowski SC. Direct visualization of RecBCD movement reveals cotranslocation of the RecD motor after chi recognition. Mol Cell. 2005;17:745–750. doi: 10.1016/j.molcel.2005.02.011. [DOI] [PubMed] [Google Scholar]
  • 35.Finkelstein IJ, Visnapuu ML, Greene EC. Single-molecule imaging reveals mechanisms of protein disruption by a DNA translocase. Nature. 2010;468:983–987. doi: 10.1038/nature09561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Wiktor J, van der Does M, Büller L, Sherratt DJ, Dekker C. Direct observation of end resection by RecBCD during double-stranded DNA break repair in vivo. Nucleic Acids Res. 2018;46:1821–1833. doi: 10.1093/nar/gkx1290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Gottesman MM, Hicks ML, Gellert M. Genetics and function of DNA ligase in Escherichia coli. J Mol Biol. 1973;77:531–547. doi: 10.1016/0022-2836(73)90221-0. [DOI] [PubMed] [Google Scholar]
  • 38.Konrad EB, Modrich P, Lehman IR. Genetic and enzymatic characterization of a conditional lethal mutant of Escherichia coli K12 with a temperature-sensitive DNA ligase. J Mol Biol. 1973;77:519–529. doi: 10.1016/0022-2836(73)90220-9. [DOI] [PubMed] [Google Scholar]
  • 39.Sriskanda V, Shuman S. A second NAD(+)-dependent DNA ligase (LigB) in Escherichia coli. Nucleic Acids Res. 2001;29:4930–4934. doi: 10.1093/nar/29.24.4930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Chayot R, Montagne B, Mazel D, Ricchetti M. An end-joining repair mechanism in Escherichia coli. Proc Natl Acad Sci USA. 2010;107:2141–2146. doi: 10.1073/pnas.0906355107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Jang S, Harshey RM. Repair of transposable phage Mu DNA insertions begins only when the E. coli replisome collides with the transpososome. Mol Microbiol. 2015;97:746–758. doi: 10.1111/mmi.13061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Charlesworth B. Fundamental concepts in genetics: Effective population size and patterns of molecular evolution and variation. Nat Rev Genet. 2009;10:195–205. doi: 10.1038/nrg2526. [DOI] [PubMed] [Google Scholar]
  • 43.Hecht SM. Bleomycin: New perspectives on the mechanism of action. J Nat Prod. 2000;63:158–168. doi: 10.1021/np990549f. [DOI] [PubMed] [Google Scholar]
  • 44.Jang S, Sandler SJ, Harshey RM. Mu insertions are repaired by the double-strand break repair pathway of Escherichia coli. PLoS Genet. 2012;8:e1002642. doi: 10.1371/journal.pgen.1002642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Howe MM. Late genes, particle morphogenesis, and DNA packaging. In: Symonds N, Toussaint A, Van de Putte P, Howe MM, editors. Phage Mu. Cold Spring Harbor Lab; Cold Spring Harbor, NY: 1987. pp. 63–74. [Google Scholar]
  • 46.Behme MT, Lilley GD, Ebisuzaki K. Postinfection control by bacteriophage T4 of Escherichia coli recBC nuclease activity. J Virol. 1976;18:20–25. doi: 10.1128/jvi.18.1.20-25.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Silverstein JL, Goldberg EB. T4 DNA injection. II. Protection of entering DNA from host exonuclease V. Virology. 1976;72:212–223. doi: 10.1016/0042-6822(76)90324-x. [DOI] [PubMed] [Google Scholar]
  • 48.Court R, Cook N, Saikrishnan K, Wigley D. The crystal structure of lambda-Gam protein suggests a model for RecBCD inhibition. J Mol Biol. 2007;371:25–33. doi: 10.1016/j.jmb.2007.05.037. [DOI] [PubMed] [Google Scholar]
  • 49.Choi W, Harshey RM. DNA repair by the cryptic endonuclease activity of Mu transposase. Proc Natl Acad Sci USA. 2010;107:10014–10019. doi: 10.1073/pnas.0912615107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Choi W, Jang S, Harshey RM. Mu transpososome and RecBCD nuclease collaborate in the repair of simple Mu insertions. Proc Natl Acad Sci USA. 2014;111:14112–14117. doi: 10.1073/pnas.1407562111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA. 2000;97:6640–6645. doi: 10.1073/pnas.120163297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Doublet B, et al. Antibiotic marker modifications of lambda Red and FLP helper plasmids, pKD46 and pCP20, for inactivation of chromosomal genes using PCR products in multidrug-resistant strains. J Microbiol Methods. 2008;75:359–361. doi: 10.1016/j.mimet.2008.06.010. [DOI] [PubMed] [Google Scholar]
  • 53.Miller JH. A Short Course in Bacterial Genetics. Cold Spring Harbor Lab Press; Cold Spring Harbor, NY: 1992. [Google Scholar]
  • 54.Yang J, et al. The I-TASSER Suite: Protein structure and function prediction. Nat Methods. 2015;12:7–8. doi: 10.1038/nmeth.3213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Guex N, Peitsch MC, Schwede T. Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: A historical perspective. Electrophoresis. 2009;30(Suppl 1):S162–S173. doi: 10.1002/elps.200900140. [DOI] [PubMed] [Google Scholar]
  • 56.Adams PD, et al. PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr. 2010;66:213–221. doi: 10.1107/S0907444909052925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Lovell SC, et al. Structure validation by Calpha geometry: Phi,psi and Cbeta deviation. Proteins. 2003;50:437–450. doi: 10.1002/prot.10286. [DOI] [PubMed] [Google Scholar]
  • 58.Altschul SF, et al. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 1997;25:3389–3402. doi: 10.1093/nar/25.17.3389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Letunic I, Bork P. Interactive tree of life (iTOL) v3: An online tool for the display and annotation of phylogenetic and other trees. Nucleic Acids Res. 2016;44:W242–W245. doi: 10.1093/nar/gkw290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Arndt D, et al. PHASTER: A better, faster version of the PHAST phage search tool. Nucleic Acids Res. 2016;44:W16–W21. doi: 10.1093/nar/gkw387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Myler LR, et al. Single-molecule imaging reveals how Mre11-Rad50-Nbs1 initiates DNA break repair. Mol Cell. 2017;67:891–898.e4. doi: 10.1016/j.molcel.2017.08.002. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary File

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES